Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Dangers of counterfeit botulinum toxin: a brief review of the literature

Dangers of counterfeit botulinum toxin: a brief review of the literature AbstractCounterfeit medicine is now a truly global phenomenon. Organised crime has become increasingly involved in counterfeiting as it has become more profitable and has lower risks than other drug crime. Although counterfeit medicines are found in legitimate UK supply chains, to date, no fatalities have been attributed to counterfeit medicine in the UK, but fatalities have occurred worldwide. While the UK legitimate pharmaceutical supply chain is tightly regulated, it is recognised that no supply chain is impenetrable. For this reason, aesthetic practitioners must ensure that the botulinum toxin type A that they use in practice for the purpose of treatment is from a reputable medical supplier, with sufficient credibility and a supportive evidence base. Ensuring patient safety is paramount to all aesthetic practitioners. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Aesthetic Nursing Mark Allen Group

Dangers of counterfeit botulinum toxin: a brief review of the literature

Journal of Aesthetic Nursing , Volume 1 (5): 4 – Nov 1, 2012

Loading next page...
 
/lp/mark-allen-group/dangers-of-counterfeit-botulinum-toxin-a-brief-review-of-the-cvzGgyLFqK
Publisher
Mark Allen Group
Copyright
Copyright © 2012 MA Healthcare Limited
ISSN
2050-3717
eISSN
2052-2878
DOI
10.12968/joan.2012.1.5.254
Publisher site
See Article on Publisher Site

Abstract

AbstractCounterfeit medicine is now a truly global phenomenon. Organised crime has become increasingly involved in counterfeiting as it has become more profitable and has lower risks than other drug crime. Although counterfeit medicines are found in legitimate UK supply chains, to date, no fatalities have been attributed to counterfeit medicine in the UK, but fatalities have occurred worldwide. While the UK legitimate pharmaceutical supply chain is tightly regulated, it is recognised that no supply chain is impenetrable. For this reason, aesthetic practitioners must ensure that the botulinum toxin type A that they use in practice for the purpose of treatment is from a reputable medical supplier, with sufficient credibility and a supportive evidence base. Ensuring patient safety is paramount to all aesthetic practitioners.

Journal

Journal of Aesthetic NursingMark Allen Group

Published: Nov 1, 2012

There are no references for this article.